Overcoming Funding Barriers for Radiopharmaceutical Innovation through Looking at Scientific & Commercial Considerations
- Analyzing the interplay between regulatory uncertainty, clinical complexity, and investor risk perception
- Prioritizing scientific strategies that improve translational success and attract sustainable funding
- Demonstrating the value proposition of next-generation TRPs to stakeholders, including patient advocates, payers, and industry partners